Filing Details
- Accession Number:
- 0001562180-19-006220
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-20 17:52:22
- Reporting Period:
- 2019-12-20
- Accepted Time:
- 2019-12-20 17:52:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1690585 | Magenta Therapeutics Inc. | MGTA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1741287 | Jr C. John Davis | C/O Magenta Therapeutics, Inc. 100 Technology Square Cambridge MA 02139 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-12-20 | 114 | $9.49 | 8,418 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-12-20 | 805 | $9.49 | 9,223 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-20 | 919 | $15.00 | 8,304 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-12-20 | 805 | $0.00 | 805 | $9.49 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-12-20 | 114 | $0.00 | 114 | $9.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 236,239 | 2028-04-25 | No | 4 | M | Direct | |
| 236,125 | 2028-04-25 | No | 4 | M | Direct |
Footnotes
- This trade is pursuant to an active 10b5-1 plan.
- 25% vested on February 16, 2019 with the remaining 75% vesting in 12 equal quarterly installments thereafter.
Billionaire Hedge Funds
